Pre-IND meeting with the FDA

InterveXion met with the FDA on September 29, 2009 to discuss plans for a Phase 1 clinical trial of the PCP antibody ch-mAb6B5. InterveXion’s management team was present with its regulatory consultant from Quintiles, Dr. Raj Kishore, and members of the NIDA management...

Believing in a Place Called Hope

Roby Brock – Talk Business Monthly Despite the fact that there are many political allusions to the title of this column, today’s words are about a fledgling business enterprise here in Arkansas. More importantly, they are about the life of a single mother who...